
Taxus
France - Four studies of three TAXUS paclitaxel-eluting stents have demonstrated their safety and efficacy, according to the maker, Boston Scientific Corporation of Natick, Maryland, USA.

France - Four studies of three TAXUS paclitaxel-eluting stents have demonstrated their safety and efficacy, according to the maker, Boston Scientific Corporation of Natick, Maryland, USA.

Russia & Netherlands - Immediate echocardiographic assessment during consultation rounds can lead to significant cost savings and can shorten the time to diagnosis, according to a new study carried out by teams at the Dept. of Cardiology, Thoraxcentre, Erasmus Medical Centre, Rotterdam and the Dept. of Internal Diseases, Medical Academy of Nizhny, Novgorod.

A newly invented 'Polypill', composed of currently available drugs, may act as a 'vaccine' against heart disease, according to new research published in the British Medical Journal (28 June. BMJ 2003;326:1419).

Arrhythmias, valve defects, heart attacks: Cardiologists face a wide range of disorders and diseases. Equally diverse are diagnostics and therapeutic options. Find out what the field has to offer.